baber/WOPTO huggingface dataset:
Patent NZ-534318-A (NZ)
Title: Prosthesis with foldable flange
Inventor: BLOM ERIC
IPC: A61F11/00
Filed: 2002-12-20
Abstract: Insertion of a flange (12) on a tubular prosthesis such as a voice prosthesis (100) through a body opening such as a tracheoesophageal fistula is facilitated by forming a thinner section (18) and a thicker section (14) on the flange, wherein the thinner section preferentially folds as the flange passes through the fistula. Retention of the flange in a gel cap is improved by forming a foldable flap extension on a cylindrical flange. A tubular tool for insertion of a tubular voice prosthesis through a fistula is also disclosed.
Patent NZ-535637-A (NZ)
Title: Self-drilling implant
Inventor: CARMICHAEL ROBERT P
IPC: A61C8/00
Filed: 2003-02-27
Abstract: In accordance with the invention, a dental implant comprises a body portion and a head portion. The body portion includes a tip portion which is remote from the head portion, a lead thread portion adjacent the tip portion, an intermediate thread portion adjacent the lead thread portion and a distal thread portion which is adjacent to the head portion. The dental implant further includes a central bore within the head portion. There is a thread within the bore for receiving a dental prosthesis. The tip portion comprises at least one cutting edge for cutting bone as the implant is rotated. The body portion includes at least one flute. The flute has a first end adjacent to the at least one cutting edge for assisting removal of bone cuttings from the cutting edge. In a more preferred embodiment of the invention, the implant includes at least two cutting edges and at least two flutes. In a particularly preferred embodiment, the flutes extend distally toward the head portion, but terminate at the end of the intermediate portion so that the distal thread portion does not have any portion thereof containing a fluted surface.
Patent NZ-536272-A (NZ)
Title: A thrombopoietin mimetic, the bis-(monoethanolamine) salt of 3'-[(2z)-[1-(3,4-dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4h-pyrazol-4-ylidene]hydrazino]-2'-hydroxy-[1,1'-biphenyl]-3-carboxylic acid
Inventor: MOORE STEPHEN
IPC: C12N5/0789
Filed: 2003-05-21
Abstract: An improved thrombopoietin mimetic, the bis-(monoethanolamine) salt of 3'-[(2Z)-[1-(3,4-dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4H-pyrazol-4-ylidene]hydrazino]-2'-hydroxy-[1,1'-biphenyl]-3-carboxylic acid and a process for manufacturing the same is disclosed. This compound is useful as an agonist of the TPO receptor, particularly in enhancing platelet production.
Patent NZ-540577-A (NZ)
Title: Tetrahydroquinoline derivatives and their use as FSH receptor modulators
Inventor: TIMMERS CORNELIS MARIUS
IPC: A61P5/08
Filed: 2003-12-16
Abstract: Disclosed herein are tetrahydroquinoline derivatives of formula (I) and a pharmaceutically acceptable salt thereof that are FSH (follicle stimulating hormone) receptor modulators, wherein R1 and R2 are H, Me; R3 is (2-6C)heterocycloalkyl(1-4C)alkyl, (2-5C)heteroaryl(1-4C)alkyl, (6C)aryl (1-4C)alkyl, (1-4C)(di)alkylaminocarbonylamino(2-4C)alkyl, (2-6C) heterocycloalkylcarbonylamino(2-4C)alkyl, R5-(2-4C)alkyl or R5-carbonyl(1-4C)alkyl; R4 is (2-5C)heteroaryl, (6C)aryl, (3-8C)cycloalkyl, (2-6C)heterocycloalkyl or (1-6C) alkyl and R5 is (di)(1-4C)alkylamino, (1-4C)alkoxy, amino, hydroxy, (6C)arylamino, (di)(3-4C)alkenylamino, (2-5C)heteroaryl(1-4C)alkylamino, (6C)aryl(1-4C) alkylamino, (di)[(1-4C)alkoxy(2-4C)alkyl]amino, (di)[(1-4C)alkylamino(2-4C) alkyl]amino, (di)[amino(2-4C)alkyl]amino or (di)[hydroxy(2-4C)alkyl]amino. Pharmaceutical compositions comprising said tetrahydroquinoline derivatives and the use of these derivatives to regulate fertility are also disclosed.
Patent NZ-542783-A (NZ)
Title: Test device, especially for testing the penetration characteristics of a sterilization agent in sterilization processes
Inventor: KAISER ULRICH
IPC: A61L2/28
Filed: 2004-03-26
Abstract: A testing body (1) is provided for verifying the penetration properties of a sterilization agent, with a compact design, a particularly high detection sensitivity and is thus particularly well-suited for use in the sterilization of minimally invasive surgical instruments that are known to be difficult to remove air therefrom thereby rendering the sterilization thereof problematic. For this purpose, the testing body (1) has a detector volume (24), which is provided for accommodating an indicator (26) and which can be connected to a sterilization chamber via a gas collecting space (4). According to the invention, the gas collecting space (4) has a multistage design, and the cross-section and the volume of each stage (14, 16) decrease between adjacent stages (14, 16) in the direction of the detector volume (24).
Patent NZ-543798-A (NZ)
Title: Method and apparatus for improving the comfort of CPAP
Inventor: FARRUGIA STEVEN PAUL
IPC: A61B5/08
Filed: 2004-06-18
Abstract: A low-cost CPAP apparatus in which, upon detection of the transition from inhalation to exhalation, the blower motor is de-energized to allow it to freewheel. When the pressure in the patient mask (or whatever interface is utilized) reaches a minimum pressure level during exhalation, the motor is re-energized and its speed is controlled so to maintain the pressure at a level suitable for exhalation. Upon detection of the transition from exhalation to inhalation, the motor speed is increased to provide higher pressures in the patient mask suitable for inhalation.
Patent NZ-549467-A (NZ)
Title: Liquefied natural gas processing
Inventor: CUELLAR KYLE T
IPC: F25J3/00
Filed: 2005-06-03
Abstract: A process and apparatus for the recovery of ethane, ethylene, propane, propylene, and heavier hydrocarbons from a liquefied natural gas (LNG) stream is disclosed. The LNG feed stream is divided into two portions. The first portion is supplied to a fractionation column at an upper mid-column feed point. The second portion is directed in heat exchange relation with a warmer distillation stream rising from the fractionation stages of the column, whereby this portion of the LNG feed stream is partially heated and the distillation stream is totally condensed. The condensed distillation stream is divided into a "lean" LNG product stream and a reflux stream, whereupon the reflux stream is supplied to the column at a top column feed position. The partially heated portion of the LNG feed stream is heated further to partially or totally vaporize it and thereafter supplied to the column at a lower mid-column feed position.
Patent NZ-553333-A (NZ)
Title: Anti-OX4OL antibodies
Inventor: ENDL JOSEF
IPC: C07K16/46
Filed: 2005-09-16
Abstract: Disclosed are anti-OX40L antibodies and, in particular, an anti-OX40L antibody and variants thereof that contains an Fc part derived from human origin, the light chain variable domain defined by SEQ ID NO: 11 or 16 and the heavy chain variable domain defined by SEQ ID NO: 12 and which does not bind complement factor C1q. Further disclosed is the use of the disclosed antibodies for the preparation of a medicament for the prophylaxis and treatment of inflammatory disorders.
Patent NZ-555441-A (NZ)
Title: Therapeutic furopyrimidines and thienopyrimidines
Inventor: BABU YARLAGADDA S
IPC: A01N43/04
Filed: 2005-10-28
Abstract: Disclosed is a furopyrimidine or thienopyrimidine of formula (I), wherein Y is O or S, R2 is a nucleoside sugar group, and the other substituents are as defined in the specification. Also disclosed is the use of the compound for treating a viral infection.
Patent NZ-555830-A (NZ)
Title: Chimeric vectors
Inventor: BOWLES DAWN E
Filed: 2005-12-15
Abstract: Disclosed are AAV capsids that can be engineered to incorporate small, selective regions from other parvoviruses that confer desirable properties. A single amino acid insertion or substitution from AAV into the capsid structure of another AAV to create a chimeric parvovirus is sufficient to confer one or more of the desirable properties of the first parvovirus to the resulting chimeric parvovirus and/or to confer a property that is not exhibited by the first parvovirus or is present to a lesser extent. Particularly an insertion into the capsid protein at position 264.
Patent NZ-562435-A (NZ)
Title: Method and system for an assessment within a multi-level organization
Inventor: YASKIN DAVID
IPC: G06Q10/00
Filed: 2006-04-12
Abstract: A method for performing assessment within a multi-level institution is disclosed. The method includes: storing a model of organisational levels of the institution, wherein each organisational level includes at least one respective, associated node; for any node, creating for and presenting to a user at least one customisable assessment project associated with that node; and completing the at least one customisable assessment project based, at least in part, on first input received from the user.
Patent NZ-562538-A (NZ)
Title: Oral sustained release compositions comprising imatinib and a release retardant
Inventor: LAKSHMAN JAY PARTHIBAN
IPC: B29C48/40
Filed: 2006-05-08
Abstract: Disclosed is an oral sustained release pharmaceutical composition comprising melt granules of imatinib or any of its salts and a release retardant, and a method of making this composition.
Patent NZ-563479-A (NZ)
Title: Device for filling of a container of collapsible type
Inventor: GUSTAFSSON PER
IPC: B65D30/16
Filed: 2006-06-02
Abstract: A device for filling a container of a collapsible type with a product in the form of powder or liquid, the container having a compartment which is defined by flexible walls and whose volume is dependent on the relative position of the walls and which communicates with the surroundings through a filling duct of the container. The device comprises a filling tube (2) with an end portion (5) , which is insertable into the filling duct of the container to supply a product to the compartment of the container through the filling tube 2. The device further comprises an end element (4) , which is arranged in an outlet (6) of the end portion (5) and which is movable between a first position, in which the end element (4) sealingly connects to the outlet (6) , and a second position, in which the end element (4) together with the outlet (6) defines a filling passage, and a squeezing means (3) , which is adapted to grasp the end portion (5) and the filling duct when the end portion (5) is inserted into the filling duct to establish a seal between the end portion (5) and the filling duct.
Patent NZ-563608-A (NZ)
Title: A mask with upper and lower stabilization parts contoured to the shape of a human face as part of the straps
Inventor: SKIPPER CHRISTOPHER SCOTT
IPC: A61M16/06
Filed: 2006-06-06
Abstract: A mask system (210) for CPAP system is disclosed. Parts of the mask (210) are preformed to conform to the shape of a human head. A plurality of headgear straps (222, 232) including a pair of upper side straps (222) and a pair of lower side straps (232) connected to a nose and mouth sealing assembly (212). An upper stabilizing element (250) extends between the sealing assembly (212) and each upper side strap (222) and a lower stabilizing element (260) extends between the sealing assembly (212) and each lower side strap (232), the upper (250) and lower (260) stabilizing elements provided to the sealing assembly (212) at distinct and spaced apart locations from one another. The stabilizing elements (250, 260) are substantially rigid and have a preformed contoured three-dimensional shape that curves rearward from the sealing assembly along at least two distinct planes and adapted to substantially match the shape of a portion of the patient's face.
Patent NZ-563882-A (NZ)
Title: Case for accommodating a medicament pack, and use thereof
Inventor: LEIFELD SABINE
IPC: B65D75/00
Filed: 2006-06-27
Abstract: The disclosure relates to a case for accommodating a blister pack, the case comprising a first half and a second half. The halves are articulated on one another. The first half of the case is designed as a pocket for accommodating the blister pack and has an outer part and an inner, transparent part as well as first through-passages in the transparent part and second through-passages in the outer part. The first through-passages are aligned, at least in part, with the second through-passages, at least where the containers are located once the blister pack has been accommodated in the pocket. The second half of the case has a first compartment for accommodating a first indicating means, which indicates days of the week, and first windows for displaying the days of the week on an inner transparent surface of the second half of the case in the region of the first compartment. The first windows are arranged such that they are aligned with the columns of containers of a medicament pack accommodated in the pocket.
Patent NZ-566007-A (NZ)
Title: (Indol-3-yl)-heterocycle derivatives as agonists of the cannabinoid cb1 receptor
Inventor: RATCLIFFE PAUL DAVID
IPC: C07D413/14
Filed: 2006-08-21
Abstract: Disclosed is an indole derivative of formula I, or a pharmaceutically acceptable salt thereof, wherein A is a 5-membered aromatic heterocyclic ring, with X1, X2, and X3 each being N, O, S, or CR, Y is CH2, O, S, or SO2, R1 is C1-4alkyl, C1-4alkyloxy, CN, or halogen, R2 and R3 may together form a 4-7 membered ring, R3 and R4 may together form a 4-8 membered ring, and wherein the other substituents are as described in the specification. Also described is the use of the compound for treating pain.
Patent NZ-572521-A (NZ)
Title: Syringe comprising an elongated hollow tubular housing having a nose with reduced cross-sectional area
Inventor: SHAW THOMAS J
IPC: A61M5/31
Filed: 2007-05-03
Abstract: Disclosed is a syringe (10) that comprises an elongated hollow tubular housing (14) having a nose (16) with a reduced cross-sectional area. A projecting structure (20) is permanently affixed or attached to the housing (14). The projecting structure (20) comprises a plurality of protruding fingers with free distal ends extending forwardly beyond and recessing the nose (16) and an open back end portion (23) with an opening and an interior wall (13) extending longitudinally between the nose (16) and the open back end portion (23). The syringe (10) further comprises an elongated plunger (24) with a plunger seal (26) that slidably engages the interior wall (13) of the housing (14). The plunger seal (26) is insertable into the housing (14) through the open back end (23). There is a second seal (40) for the nose (16). The second seal (40) is a removable closure disposed over the nose (16). The interior wall (13) defines a fluid chamber (15) disposed in the housing (14) between the second seal (40) for the nose (16) and the plunger seal (26).
Patent NZ-573049-A (NZ)
Title: Spirocyclic nitriles as protease inhibitors
Inventor: SCHUDOK MANFRED
IPC: A61K31/438
Filed: 2007-05-23
Abstract: Disclosed are spirocyclic compounds of the general formula la, where the sub-rings A and B are in each case the same or different and are each independently a) a saturated or partly saturated cycloalkyl, in which cycloalkyl is unbridged, bridged or fused and is unsubstituted or independently, according to the ring size, mono-, di-, tri, tetra- or pentasubstituted by R4, or b) a saturated or partly saturated, heterocycle which, according to the ring size, may contain one, two, three or four identical or different heteroatoms from the group of oxygen, nitrogen or sulphur, and in which the heterocycle is unbridged, bridged or fused and is unsubstituted or independently, according to the ring size, mono-, di-, tri-, tetra- or pentasubstituted by R4; and wherein the remaining substituents are as defined herein. Also disclosed is a medicament which comprises a compound of the formula la as defined above together with a pharmaceutically suitable and physiologically compatible carrier, additive and/or other active ingredients and/or excipients.
Patent NZ-573417-A (NZ)
Title: Methods and compositions for modulating hepsin activation of urokinase-type plasminogen activator
Inventor: KIRCHHOFER DANIEL K
IPC: G01N33/50
Filed: 2007-06-20
Abstract: Disclosed is the use of an antagonist molecule that inhibits hepsin activation of pro-urokinase type plasminogen activator (pro-uPA) in the manufacture of a medicament for treating cancer, wherein the antagonist molecule comprises: (i) a polypeptide comprising a Kunitz domain (KD) sequence; (ii) at least a portion of human hepatocyte growth factor activator inhibitor-1, -1B, or -2 (HAT-1, HAT-1B or HAI-2); (iii) an amino acid sequence having at least about 70%, 80%, 90%, 95% or 99% sequence identity to pro-uPA and which is capable of binding hepsin and which lacks a hepsin cleavage site. Also disclosed is the molecule linked to a toxin.
Patent NZ-584970-A (NZ)
Title: Continuous method for the heterogenically catalyzed esterification of fatty acids
Inventor: HEINZ DIETER
IPC: C07C67/03
Filed: 2008-10-16
Abstract: Disclosed herein is a continuous process for esterifying free fatty acids present in oils and/or fats of vegetable or animal origin, characterized by at least the steps of: 1) removing the free fatty acids from said oils and/or fats by means of distillation or rectification, 2) reacting the deacidified oils and/or fats remaining after step 1) in the form of a transesterification to obtain fatty acid alkyl esters, 3) reacting the free fatty acids with alcohols using at least one acidic catalyst in a fixed bed, in the form of an esterification reaction, 4) removing the water formed as a by-product in step 3), optionally together with at least a portion of the alcohol unconverted in step 3), 5) further converting the dewatered product obtained from step 4), optionally with addition of further alcohol, using at least one acidic catalyst in a fixed bed, in the form of an esterification reaction, 6) mixing the reaction product obtained from 5) with the remaining oils and/or fats obtained from step 1) and/or the fatty acid alkyl esters obtained from step 2). Also disclosed is the use of the above process for producing biodiesel.
Patent NZ-589594-A (NZ)
Title: Eco-friendly flexible hose and method of manufacturing thereof
Inventor: MEZZALIRA ALESSANDRO
IPC: F16L11/02
Filed: 2010-11-29
Abstract: Disclosed herein is a flexible hose for carrying liquids, comprising at least one first layer made of a first plasticized compound consisting of: (a) 20% to 80% by weight of a PVC matrix; (b) 10% to 50% by weight of a plasticizer agent; (c) 0.1% to 5% by weight of a stabilizer agent; (d) 0.1 to 50% by weight of at least one vegetable filler; (e) 0% to 50% by weight of at least one additive; (f) 0% to 40% by weight of at least one elastomer compatible with said PVC matrix a) wherein: · the total of the percentages by weight of the components (a) to (f) is 100%; · the first plasticized PVC compound has a Shore A hardness of 60 to 90; · said at least one vegetable filler (d) is 0.1% to 35% by weight if said elastomer (f) is 0% or less than 5% by weight.
Patent NZ-596609-A (NZ)
Title: Biological reactor vessel and method for aerobic, anaerobic or anoxic purification of wastewater, wherein the reactor vessel is filled with carrier elements, on which a biofilm forms
Inventor: WESTRUM THORBJ RN
IPC: C02F3/08
Filed: 2010-06-03
Abstract: 596609 A reactor (4) for aerobic, anoxic or anaerobic purification of waste water is disclosed. The reactor comprises one or more inlet pipes (1), one or more inlet zones, one or more outlet zones (7) and outlet pipes (2) for water and substrate, one or more outlet pipes for sludge (3), and one or more mixing mechanisms (6) for transport of water and substrate. The reactor also comprises a filling of carrier elements (5), on which a biofilm may form. 90%-100% of the reactor liquid volume may be constituted by the biofilm carrier elements during normal operation of the reactor. During normal operation, the carrier elements are not free to move. During sludge removal the water level in the reactor is raised such that the carrier elements become fluidised and are able to move freely with the help of one or more of the mixing mechanisms. A method for biological purification of water is also disclosed.
Patent NZ-597289-A (NZ)
Title: Beverage packaging
Inventor: KAMBOURIS AMBROSIOS
IPC: B65D77/06
Filed: 2010-05-20
Abstract: A beverage storage apparatus including an outer container housing an internal flexible and collapsible bladder serving to hold the beverage and a means to regulate the pressure of gas in a head space between the outer container and the internal bladder. The apparatus can further dispense fluid such as beverages whereupon the bladder is under pressure to assist in dispensing the fluid and by use of an appropriate gas maintain the composition of the beverage.
Patent NZ-602195-A (NZ)
Title: Lip smoking article wrapper, smoking article, method and apparatus
Inventor: KALJURA KARL
IPC: A24D1/02
Filed: 2011-03-15
Abstract: 602195 Disclosed is a low ignition propensity wrapper for a cigarette allowing improved gas permeability and carbon dioxide (CO2) gas diffusivity. The wrapper comprises a first embossed region and a second non-embossed or differently embossed region, where the first region has a higher permeability than the second region; and a higher gas diffusivity than the second region. A low ignition propensity smoking article incorporating the wrapper and an apparatus and a method for forming the wrapper are also described.
Patent NZ-623138-A (NZ)
Title: Antiseptic cap with thread cover
Inventor: ANDERSON WILLIAM
IPC: A61M39/20
Filed: 2008-06-22
Abstract: Disclosed is an antiseptic cap for a catheter access site to maintain sterility of the thread connection. The antiseptic cap comprises a housing having a generally cylindrical side wall defining a chamber having an open upper end and an end wall closing the opposite end. The generally cylindrical side wall has an inner surface with threads extending along a portion of the inner surface. An antiseptic material is coated on the inner surface of the generally cylindrical side wall and an antiseptic coating is on an external surface of the generally cylindrical side wall. An actuating post extends from the end wall of the housing, the actuating post having an antiseptic coating thereon. The antiseptic material is coated on the inner surface of the generally cylindrical side wall by immersion of the inner surface into an antiseptic solution or by spray coating the inner surface with an antiseptic solution, or by blending an antiseptic solution or material into a polymeric material and forming the inner surface therefrom.
Patent NZ-630009-A (NZ)
Title: Angiogenesis using placental stem cells
Inventor: KAPLUNOVSKY ALEKSANDR
IPC: A61K35/28
Filed: 2011-04-06
Abstract: Disclosed is the use of placental stem cells in the manufacture of a medicament for treating an individual having a disease or disorder of the circulatory system, wherein (i) treatment of said individual with said placental stem cells results in a detectable improvement of one or more symptoms of said disease or disorder, (ii) said placental stem cells are capable of inducing angiogenesis, (iii) said disease or disorder of the circulatory system is peripheral arterial disease, critical limb ischemia, peripheral vascular disease, or diabetic ulcer, and (iv) said placental stem cells express the ELOVL2 gene at a detectably higher level than an equivalent number of bone marrow-derived mesenchymal stem cells.